Medical Nitrous Oxide Market by Product (Gas, Liquid), Application (Anaesthesia, Pain, Cryosurgery, Surgical Insufflation), End User (Hospital, Home healthcare, Academic, Research Institution), Key Stakeholder & Buying Criteria - Global Forecast to 2029
The global medical nitrous oxide market size is estimated to be USD 2.8 billion by 2029, from USD 1.8 billion in 2023, at a CAGR of 6.6%. The expansion of the medical nitrous oxide market is primarily fueled by various factors, including the increasing elderly population, advancements in healthcare infrastructure, a desire for non-invasive pain relief methods, and the existence of supportive regulations governing medical gas usage. Furthermore, the surge in surgical procedures, evident in both developed and developing nations, creates a favorable opportunity for the heightened utilization of medical nitrous oxide in anesthesia and analgesia, paving the way for additional growth prospects in the industry.
“The gasesous segment is expected to account for the largest market share in 2023.”
The medical nitrous oxide market is segmented based on product into gaseous and liquid states. As of 2023, the gaseous segment dominated the market. The prevalence of the gaseous state in the medical nitrous oxide market is attributed to its versatility in applications, particularly in anesthesia and analgesia during surgical procedures. The preference for the gaseous form in medical environments is driven by its ease of administration, precise dosage control, and rapid onset of action.
“The anesthesia and pain relief segment to register the highest growth rate in the forecast period.”
The medical nitrous oxide market, by application is segmented into anesthesia and pain relief, cryosurgery, and surgical insufflation. As of 2023, the anesthesia and pain relief segment is expected to register the highest growth during the forecast period. The dominance of anesthesia and pain relief applications in the medical nitrous oxide market is credited to their pivotal roles in both surgical and medical procedures. Nitrous oxide, celebrated for its anesthetic and analgesic properties, is widely embraced in healthcare settings due to its effectiveness in inducing conscious sedation and relieving pain during various medical interventions. This dominance is emphasized by the widespread use of nitrous oxide by healthcare professionals, as it offers swift and controllable sedation, significantly enhancing patient comfort and procedural success.
The hospital segment accounted for the largest share of the brain monitoring market in 2023.
The medical nitrous oxide market is classified by end user into hospitals, home healthcare, and academic and research institutions. As of 2023, the hospitals segment dominated the market. This is primarily due to the crucial role of nitrous oxide within hospital settings, particularly in the context of surgical and medical procedures. Hospitals, serving as central hubs for comprehensive healthcare services, extensively employ nitrous oxide for anesthesia and analgesia, offering a controlled and effective method for patient sedation during surgical interventions.
“North America to be the largest regional segment in the medical nitrous oxide market during the forecast period.”
Based on the region, the global medical nitrous oxide market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the market in 2023. The Asia Pacific region is anticipated to experience the most rapid growth during the forecast period. The significant expansion of the market in the Asia Pacific can be attributed to the dynamic growth in healthcare infrastructure, a rise in surgical procedures, and an increasing awareness of the advantages of nitrous oxide. These factors collectively contribute to an increased demand for medical nitrous oxide in the APAC region.
Breakdown of primaries
The break of primary participants was as mentioned below:
Research Coverage:
The report segments the medical nitrous oxide market based on region (Asia Pacific, Europe, North America, Latin America, and Middle East & Africa), Product (gasesous, liquid), application (anesthesia and pain relief, cryosurgery, and surgical inflation), and end user(hospitals, home healthcare, and academic and research institutions).
The report also provides a comprehensive review of market drivers, restraints, and opportunities in the medical nitrous oxide market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the medical nitrous oxide market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
.
“The gasesous segment is expected to account for the largest market share in 2023.”
The medical nitrous oxide market is segmented based on product into gaseous and liquid states. As of 2023, the gaseous segment dominated the market. The prevalence of the gaseous state in the medical nitrous oxide market is attributed to its versatility in applications, particularly in anesthesia and analgesia during surgical procedures. The preference for the gaseous form in medical environments is driven by its ease of administration, precise dosage control, and rapid onset of action.
“The anesthesia and pain relief segment to register the highest growth rate in the forecast period.”
The medical nitrous oxide market, by application is segmented into anesthesia and pain relief, cryosurgery, and surgical insufflation. As of 2023, the anesthesia and pain relief segment is expected to register the highest growth during the forecast period. The dominance of anesthesia and pain relief applications in the medical nitrous oxide market is credited to their pivotal roles in both surgical and medical procedures. Nitrous oxide, celebrated for its anesthetic and analgesic properties, is widely embraced in healthcare settings due to its effectiveness in inducing conscious sedation and relieving pain during various medical interventions. This dominance is emphasized by the widespread use of nitrous oxide by healthcare professionals, as it offers swift and controllable sedation, significantly enhancing patient comfort and procedural success.
The hospital segment accounted for the largest share of the brain monitoring market in 2023.
The medical nitrous oxide market is classified by end user into hospitals, home healthcare, and academic and research institutions. As of 2023, the hospitals segment dominated the market. This is primarily due to the crucial role of nitrous oxide within hospital settings, particularly in the context of surgical and medical procedures. Hospitals, serving as central hubs for comprehensive healthcare services, extensively employ nitrous oxide for anesthesia and analgesia, offering a controlled and effective method for patient sedation during surgical interventions.
“North America to be the largest regional segment in the medical nitrous oxide market during the forecast period.”
Based on the region, the global medical nitrous oxide market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the market in 2023. The Asia Pacific region is anticipated to experience the most rapid growth during the forecast period. The significant expansion of the market in the Asia Pacific can be attributed to the dynamic growth in healthcare infrastructure, a rise in surgical procedures, and an increasing awareness of the advantages of nitrous oxide. These factors collectively contribute to an increased demand for medical nitrous oxide in the APAC region.
Breakdown of primaries
The break of primary participants was as mentioned below:
- By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation – C-level–35%, Director-level–25%, Others–40%
- By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
Research Coverage:
The report segments the medical nitrous oxide market based on region (Asia Pacific, Europe, North America, Latin America, and Middle East & Africa), Product (gasesous, liquid), application (anesthesia and pain relief, cryosurgery, and surgical inflation), and end user(hospitals, home healthcare, and academic and research institutions).
The report also provides a comprehensive review of market drivers, restraints, and opportunities in the medical nitrous oxide market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the medical nitrous oxide market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
.
- Analysis of key drivers (growing aging population, advancements in healthcare infrastructure, demand for non-invasive methods for pain relief, and supportive regulations and standards regarding the use of medical gases), restraints (safery concerns, availability of alternatives, environmental concerns), opportunities (emerging markets, pediatric applications), challenges (limited awareness, economic factors).
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global medical nitrous oxide market. The report analyzes this market by products, application, and end users.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global medical nitrous oxide market
- Market Development: Comprehensive information on the lucrative emerging markets by products, application, and end users.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global medical nitrous oxide market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global medical nitrous oxide market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKETS COVERED
FIGURE 1 MEDICAL NITROUS OXIDE MARKET SEGMENTATION
1.3.1 REGIONAL SEGMENTATION
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews: by company type, designation, and region
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3 MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MEDICAL NITROUS OXIDE MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR AIR LIQUIDE S.A.
FIGURE 6 MEDICAL NITROUS OXIDE MARKET: DEMAND-SIDE MODELING
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL NITROUS OXIDE MARKET (2023–2029)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 SCOPE-RELATED LIMITATIONS
2.6.2 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: MEDICAL NITROUS OXIDE MARKET
2.8 MEDICAL NITROUS OXIDE MARKET: RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 10 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION)
FIGURE 11 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
FIGURE 12 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL NITROUS OXIDE MARKET
4 PREMIUM INSIGHTS
4.1 MEDICAL NITROUS OXIDE MARKET OVERVIEW
FIGURE 14 INCREASING NUMBER OF SURGERIES AND DENTAL PROCEDURES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 15 LIQUID NITROUS OXIDE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
4.3 MEDICAL NITROUS OXIDE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 MEDICAL NITROUS OXIDE MARKET: REGIONAL MIX
FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 MEDICAL NITROUS OXIDE MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 MEDICAL NITROUS OXIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing number of surgeries and dental procedures
5.2.1.2 Growing adoption of nitrous oxide across various medical specialties
5.2.1.3 Rising geriatric population and subsequent increase in prevalence of chronic diseases
FIGURE 20 GLOBAL GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION)
5.2.1.4 Growing demand for home healthcare
5.2.2 RESTRAINTS
5.2.2.1 Potential risks associated with nitrous oxide misuse
5.2.2.2 Availability of alternatives
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for pain management
FIGURE 21 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021
5.2.3.2 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Changes in calibration standards
5.2.4.2 Lack of awareness
5.3 INDUSTRY TRENDS
5.3.1 ADVANCEMENTS IN NITROUS OXIDE DELIVERY SYSTEMS
5.3.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Nitrous oxide delivery systems
5.4.1.2 Monitoring and control systems
5.4.1.3 Technological integration in anesthesia machines
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Patient monitoring devices
5.4.2.2 Smart devices and connectivity
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Advanced anesthetic agents
5.4.3.2 Surgical robotics
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF MEDICAL NITROUS OXIDE, BY PRODUCT
TABLE 3 AVERAGE SELLING PRICE OF MEDICAL NITROUS OXIDE, BY PRODUCT TYPE (USD)
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PORTER’S FIVE FORCES ANALYSIS
5.6.1 INTENSITY OF COMPETITIVE RIVALRY
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 THREAT OF NEW ENTRANTS
5.7 TARIFF & REGULATORY ANALYSIS
5.7.1 TARIFF FOR MEDICAL NITROUS OXIDE
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.3 NORTH AMERICA
5.7.3.1 US
TABLE 5 US: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.3.2 Canada
TABLE 6 CANADA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.4 EUROPE
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.7.5 ASIA PACIFIC
5.7.5.1 Japan
TABLE 8 JAPAN: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.5.2 China
TABLE 9 CHINA: STANDARDS FOR MEDICAL GAS EQUIPMENT
TABLE 10 CHINA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.5.3 India
TABLE 11 INDIA: STANDARDS FOR MEDICAL GAS EQUIPMENT
TABLE 12 INDIA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.6 LATIN AMERICA AND MIDDLE EAST & AFRICA
TABLE 13 LATIN AMERICA AND MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
TABLE 14 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM MAPPING
FIGURE 23 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY: EAST LANCASHIRE TEACHING HOSPITAL NHS FOUNDATION TRUST (ELHT)
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS
FIGURE 24 PATENT PUBLICATION TRENDS, 2014–2024
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024)
TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL NITROUS OXIDE PATENTS
5.11.3 MEDICAL NITROUS OXIDE MARKET: TOP APPLICANTS
FIGURE 25 TOP APPLICANTS FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024)
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE PRODUCTS
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE END USERS
5.12.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA FOR END USERS IN MEDICAL NITROUS OXIDE MARKET
TABLE 18 KEY BUYING CRITERIA FOR MEDICAL NITROUS OXIDE MARKET
5.13 KEY CONFERENCES & EVENTS IN 2024
TABLE 19 MEDICAL NITROUS OXIDE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.14 TRADE ANALYSIS
5.14.1 TRADE ANALYSIS FOR MEDICAL NITROUS OXIDE
FIGURE 28 PRODUCT IMPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
FIGURE 29 PRODUCT EXPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 30 REVENUE SHIFT IN MEDICAL NITROUS OXIDE MARKET
5.16 UNMET NEEDS ANALYSIS
TABLE 20 UNMET NEEDS IN MEDICAL NITROUS OXIDE MARKET
5.16.1 END-USER EXPECTATIONS
TABLE 21 END-USER EXPECTATIONS IN MEDICAL NITROUS OXIDE MARKET
6 MEDICAL NITROUS OXIDE MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 22 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 23 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.2 LIQUID NITROUS OXIDE
6.2.1 RISING CRYOTHERAPY APPLICATIONS TO DRIVE MARKET
TABLE 24 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 25 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3 GASEOUS NITROUS OXIDE
6.3.1 PRECISE DOSAGE CONTROL AND PORTABILITY TO DRIVE MARKET GROWTH
TABLE 26 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 27 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 28 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 29 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
7.2 ANESTHESIA & PAIN RELIEF
7.2.1 WIDE USAGE AS CARRIER FOR OTHER ANESTHETIC GASES TO DRIVE MARKET
TABLE 30 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 31 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 CRYOSURGERY
7.3.1 PAINLESSNESS OF CRYOSURGICAL PROCEDURES TO SUPPORT ADOPTION
TABLE 32 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 33 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
7.4 SURGICAL INSUFFLATION
7.4.1 USE OF NITROUS OXIDE AS INSUFFLATION GAS IN LAPAROSCOPIC AND ENDOSCOPIC SURGERIES TO DRIVE MARKET
TABLE 34 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 35 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2022–2029 (USD MILLION)
8 MEDICAL NITROUS OXIDE MARKET, BY END USER
8.1 INTRODUCTION
TABLE 36 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 37 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
8.2 HOSPITALS
8.2.1 EXTENSIVE USAGE OF MEDICAL NITROUS OXIDE TO DRIVE MARKET
TABLE 38 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 39 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 HOME CARE SETTINGS TO WITNESS HIGHEST GROWTH DUE TO RISING PREVALENCE OF CHRONIC DISEASES
TABLE 40 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 41 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 COLLABORATION WITH INDUSTRY PARTNERS FOR TECHNOLOGICAL ADVANCES TO SUPPORT GROWTH
TABLE 42 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 43 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
9 MEDICAL NITROUS OXIDE MARKET, BY REGION
9.1 INTRODUCTION
TABLE 44 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 45 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 31 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
TABLE 46 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 47 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 49 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 50 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 51 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 52 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 53 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American medical nitrous oxide market
TABLE 54 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 55 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 56 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 57 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 58 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 59 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Stringent regulatory compliance to support market growth in Canada
TABLE 60 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 61 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 62 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 63 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 64 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 65 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 66 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 67 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 69 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 70 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 71 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 72 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 73 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Increasing healthcare spending to drive market
TABLE 74 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 75 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 76 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 77 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 78 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 79 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.3 UK
9.3.3.1 Increasing surgeries & dental procedures to drive market
TABLE 80 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 81 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 82 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 83 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 84 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 85 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Well-established healthcare system to drive market
TABLE 86 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 87 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 88 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 89 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 90 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 91 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Rapid growth in geriatric population and rising life expectancy to favor market growth
TABLE 92 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 93 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 94 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 95 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 96 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 97 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Increasing prevalence of cancer to support market growth
TABLE 98 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 99 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 100 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 101 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 102 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 103 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 104 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 105 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 106 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 107 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 108 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 109 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 32 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 111 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 113 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 114 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 115 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 117 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Japan to hold largest share of APAC market
TABLE 118 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 119 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 120 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 121 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 122 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 123 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Strong investments in infrastructural development to offer opportunities for market growth
TABLE 124 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 125 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 126 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 127 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 128 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 129 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Rising procedural volume to ensure sustained demand for medical gases
TABLE 130 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 131 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 132 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 133 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 134 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 135 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 136 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 139 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 140 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING PUBLIC-PRIVATE PARTNERSHIPS FOR HEALTHCARE DEVELOPMENT TO PROMOTE ADOPTION OF MEDICAL NITROUS OXIDE
9.5.2 LATIN AMERICA: RECESSION IMPACT
TABLE 142 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 143 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 144 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 145 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 146 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 147 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 148 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 154 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL NITROUS OXIDE MARKET
10.3 REVENUE ANALYSIS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL NITROUS OXIDE MARKET, 2018–2022 (USD MILLION)
10.4 MARKET SHARE ANALYSIS
FIGURE 34 MEDICAL NITROUS OXIDE MARKET SHARE ANALYSIS (2022)
TABLE 155 MEDICAL NITROUS OXIDE MARKET: DEGREE OF COMPETITION
10.5 MARKET RANKING ANALYSIS
FIGURE 35 MEDICAL NITROUS OXIDE MARKET RANKING, BY KEY PLAYER, 2022
10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 36 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
10.6.5 COMPANY FOOTPRINT
FIGURE 37 MEDICAL NITROUS OXIDE MARKET: COMPANY FOOTPRINT
TABLE 156 MEDICAL NITROUS OXIDE MARKET: TYPE FOOTPRINT
TABLE 157 MEDICAL NITROUS OXIDE MARKET: APPLICATION FOOTPRINT
TABLE 158 MEDICAL NITROUS OXIDE MARKET: END-USER FOOTPRINT
TABLE 159 MEDICAL NITROUS OXIDE MARKET: REGIONAL FOOTPRINT
10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES
10.7.1 PROGRESSIVE COMPANIES
10.7.2 RESPONSIVE COMPANIES
10.7.3 DYNAMIC COMPANIES
10.7.4 STARTING BLOCKS
FIGURE 38 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
10.7.5 COMPETITIVE BENCHMARKING
10.7.5.1 Detailed list of key startups/SMEs
TABLE 160 MEDICAL NITROUS OXIDE: DETAILED LIST OF KEY STARTUPS/SMES
10.7.5.2 Competitive benchmarking of key startups/SMEs
TABLE 161 MEDICAL NITROUS OXIDE: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPANY EVALUATION AND FINANCIAL METRICS
FIGURE 39 EV/EBITDA OF KEY VENDORS
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL NITROUS OXIDE VENDORS
10.10 COMPETITIVE SCENARIO
10.10.1 DEALS
TABLE 162 MEDICAL NITROUS OXIDE MARKET: DEALS, JANUARY 2020– JANUARY 2024
10.10.2 EXPANSIONS
TABLE 163 MEDICAL NITROUS OXIDE MARKET: EXPANSIONS, JANUARY 2020–JANUARY 2024
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 AIR LIQUIDE
TABLE 164 AIR LIQUIDE: COMPANY OVERVIEW
FIGURE 41 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
11.1.2 LINDE PLC
TABLE 165 LINDE PLC: COMPANY OVERVIEW
FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2022)
11.1.3 SOL SPA
TABLE 166 SOL SPA: COMPANY OVERVIEW
FIGURE 43 SOL SPA: COMPANY SNAPSHOT (2022)
11.1.4 TAIYO NIPPON SANSO CORPORATION
TABLE 167 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW
FIGURE 44 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2023)
11.1.5 NORCO INC.
TABLE 168 NORCO INC.: COMPANY OVERVIEW
11.1.6 SOUTHERN GAS LIMITED
TABLE 169 SOUTHERN GAS LIMITED: COMPANY OVERVIEW
FIGURE 45 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2022)
11.1.7 ELLENBARRIE INDUSTRIAL GASES
TABLE 170 ELLENBARRIE INDUSTRIAL GASES: COMPANY OVERVIEW
FIGURE 46 ELLENBARRIE INDUSTRIAL GASES: COMPANY SNAPSHOT (2020)
11.1.8 CALOX INC.
TABLE 171 CALOX INC.: COMPANY OVERVIEW
11.1.9 STEELMAN GASES PVT. LTD.
TABLE 172 STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW
11.1.10 NEXAIR
TABLE 173 NEXAIR: COMPANY OVERVIEW
11.1.11 OXYGEN & ARGON WORKS LTD.
TABLE 174 OXYGEN & ARGON WORKS LTD.: COMPANY OVERVIEW
11.1.12 GULFCRYO
TABLE 175 GULFCRYO: COMPANY OVERVIEW
11.1.13 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
TABLE 176 CHENGDU TAIYO INDUSTRIAL GASES CO. LTD.: COMPANY OVERVIEW
11.1.14 JIANGSU HUAZHONG GAS CO., LTD.
TABLE 177 JIANGSU HAUZHONG GAS CO., LTD.: COMPANY OVERVIEW
11.1.15 CARBIDE AND CHEMICALS
TABLE 178 CARBIDE AND CHEMICALS: COMPANY OVERVIEW
11.1.16 AMERICAN WELDING & GAS
TABLE 179 AMERICAN WELDING & GAS: COMPANY OVERVIEW
11.1.17 ASIA INDUSTRIAL GASES PTE. LTD.
TABLE 180 ASIA INDUSTRIAL GASES PTE. LTD.: COMPANY OVERVIEW
11.1.18 MIDDLESEX GASES & TECHNOLOGY INC.
TABLE 181 MIDDLESEX GASES & TECHNOLOGIES INC.: COMPANY OVERVIEW
11.1.19 AMERITANX CYLINDERS
TABLE 182 AMERITANX CYLINDERS: COMPANY OVERVIEW
11.1.20 CRYOCARB
TABLE 183 CRYOCARB: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 HOLSTON GASES
11.2.2 AOPL
11.2.3 BUTLER GAS PRODUCTS COMPANY
11.2.4 GRUPPO SIAD
11.2.5 ANDY OXY CO., INC.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKETS COVERED
FIGURE 1 MEDICAL NITROUS OXIDE MARKET SEGMENTATION
1.3.1 REGIONAL SEGMENTATION
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews: by company type, designation, and region
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3 MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MEDICAL NITROUS OXIDE MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR AIR LIQUIDE S.A.
FIGURE 6 MEDICAL NITROUS OXIDE MARKET: DEMAND-SIDE MODELING
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL NITROUS OXIDE MARKET (2023–2029)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 SCOPE-RELATED LIMITATIONS
2.6.2 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: MEDICAL NITROUS OXIDE MARKET
2.8 MEDICAL NITROUS OXIDE MARKET: RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 10 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION)
FIGURE 11 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
FIGURE 12 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL NITROUS OXIDE MARKET
4 PREMIUM INSIGHTS
4.1 MEDICAL NITROUS OXIDE MARKET OVERVIEW
FIGURE 14 INCREASING NUMBER OF SURGERIES AND DENTAL PROCEDURES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 15 LIQUID NITROUS OXIDE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
4.3 MEDICAL NITROUS OXIDE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 MEDICAL NITROUS OXIDE MARKET: REGIONAL MIX
FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 MEDICAL NITROUS OXIDE MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 MEDICAL NITROUS OXIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing number of surgeries and dental procedures
5.2.1.2 Growing adoption of nitrous oxide across various medical specialties
5.2.1.3 Rising geriatric population and subsequent increase in prevalence of chronic diseases
FIGURE 20 GLOBAL GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION)
5.2.1.4 Growing demand for home healthcare
5.2.2 RESTRAINTS
5.2.2.1 Potential risks associated with nitrous oxide misuse
5.2.2.2 Availability of alternatives
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for pain management
FIGURE 21 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021
5.2.3.2 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Changes in calibration standards
5.2.4.2 Lack of awareness
5.3 INDUSTRY TRENDS
5.3.1 ADVANCEMENTS IN NITROUS OXIDE DELIVERY SYSTEMS
5.3.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Nitrous oxide delivery systems
5.4.1.2 Monitoring and control systems
5.4.1.3 Technological integration in anesthesia machines
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Patient monitoring devices
5.4.2.2 Smart devices and connectivity
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Advanced anesthetic agents
5.4.3.2 Surgical robotics
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF MEDICAL NITROUS OXIDE, BY PRODUCT
TABLE 3 AVERAGE SELLING PRICE OF MEDICAL NITROUS OXIDE, BY PRODUCT TYPE (USD)
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PORTER’S FIVE FORCES ANALYSIS
5.6.1 INTENSITY OF COMPETITIVE RIVALRY
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 THREAT OF NEW ENTRANTS
5.7 TARIFF & REGULATORY ANALYSIS
5.7.1 TARIFF FOR MEDICAL NITROUS OXIDE
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.3 NORTH AMERICA
5.7.3.1 US
TABLE 5 US: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.3.2 Canada
TABLE 6 CANADA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.4 EUROPE
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.7.5 ASIA PACIFIC
5.7.5.1 Japan
TABLE 8 JAPAN: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.5.2 China
TABLE 9 CHINA: STANDARDS FOR MEDICAL GAS EQUIPMENT
TABLE 10 CHINA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.5.3 India
TABLE 11 INDIA: STANDARDS FOR MEDICAL GAS EQUIPMENT
TABLE 12 INDIA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.6 LATIN AMERICA AND MIDDLE EAST & AFRICA
TABLE 13 LATIN AMERICA AND MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
TABLE 14 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM MAPPING
FIGURE 23 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY: EAST LANCASHIRE TEACHING HOSPITAL NHS FOUNDATION TRUST (ELHT)
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS
FIGURE 24 PATENT PUBLICATION TRENDS, 2014–2024
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024)
TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL NITROUS OXIDE PATENTS
5.11.3 MEDICAL NITROUS OXIDE MARKET: TOP APPLICANTS
FIGURE 25 TOP APPLICANTS FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024)
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE PRODUCTS
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE END USERS
5.12.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA FOR END USERS IN MEDICAL NITROUS OXIDE MARKET
TABLE 18 KEY BUYING CRITERIA FOR MEDICAL NITROUS OXIDE MARKET
5.13 KEY CONFERENCES & EVENTS IN 2024
TABLE 19 MEDICAL NITROUS OXIDE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.14 TRADE ANALYSIS
5.14.1 TRADE ANALYSIS FOR MEDICAL NITROUS OXIDE
FIGURE 28 PRODUCT IMPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
FIGURE 29 PRODUCT EXPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 30 REVENUE SHIFT IN MEDICAL NITROUS OXIDE MARKET
5.16 UNMET NEEDS ANALYSIS
TABLE 20 UNMET NEEDS IN MEDICAL NITROUS OXIDE MARKET
5.16.1 END-USER EXPECTATIONS
TABLE 21 END-USER EXPECTATIONS IN MEDICAL NITROUS OXIDE MARKET
6 MEDICAL NITROUS OXIDE MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 22 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 23 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.2 LIQUID NITROUS OXIDE
6.2.1 RISING CRYOTHERAPY APPLICATIONS TO DRIVE MARKET
TABLE 24 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 25 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3 GASEOUS NITROUS OXIDE
6.3.1 PRECISE DOSAGE CONTROL AND PORTABILITY TO DRIVE MARKET GROWTH
TABLE 26 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 27 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 28 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 29 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
7.2 ANESTHESIA & PAIN RELIEF
7.2.1 WIDE USAGE AS CARRIER FOR OTHER ANESTHETIC GASES TO DRIVE MARKET
TABLE 30 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 31 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 CRYOSURGERY
7.3.1 PAINLESSNESS OF CRYOSURGICAL PROCEDURES TO SUPPORT ADOPTION
TABLE 32 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 33 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
7.4 SURGICAL INSUFFLATION
7.4.1 USE OF NITROUS OXIDE AS INSUFFLATION GAS IN LAPAROSCOPIC AND ENDOSCOPIC SURGERIES TO DRIVE MARKET
TABLE 34 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 35 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2022–2029 (USD MILLION)
8 MEDICAL NITROUS OXIDE MARKET, BY END USER
8.1 INTRODUCTION
TABLE 36 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 37 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
8.2 HOSPITALS
8.2.1 EXTENSIVE USAGE OF MEDICAL NITROUS OXIDE TO DRIVE MARKET
TABLE 38 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 39 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 HOME CARE SETTINGS TO WITNESS HIGHEST GROWTH DUE TO RISING PREVALENCE OF CHRONIC DISEASES
TABLE 40 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 41 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 COLLABORATION WITH INDUSTRY PARTNERS FOR TECHNOLOGICAL ADVANCES TO SUPPORT GROWTH
TABLE 42 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 43 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
9 MEDICAL NITROUS OXIDE MARKET, BY REGION
9.1 INTRODUCTION
TABLE 44 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 45 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 31 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
TABLE 46 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 47 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 49 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 50 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 51 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 52 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 53 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American medical nitrous oxide market
TABLE 54 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 55 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 56 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 57 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 58 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 59 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Stringent regulatory compliance to support market growth in Canada
TABLE 60 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 61 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 62 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 63 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 64 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 65 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 66 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 67 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 69 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 70 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 71 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 72 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 73 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Increasing healthcare spending to drive market
TABLE 74 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 75 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 76 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 77 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 78 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 79 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.3 UK
9.3.3.1 Increasing surgeries & dental procedures to drive market
TABLE 80 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 81 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 82 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 83 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 84 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 85 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Well-established healthcare system to drive market
TABLE 86 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 87 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 88 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 89 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 90 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 91 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Rapid growth in geriatric population and rising life expectancy to favor market growth
TABLE 92 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 93 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 94 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 95 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 96 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 97 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Increasing prevalence of cancer to support market growth
TABLE 98 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 99 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 100 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 101 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 102 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 103 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 104 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 105 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 106 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 107 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 108 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 109 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 32 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 111 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 113 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 114 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 115 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 117 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Japan to hold largest share of APAC market
TABLE 118 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 119 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 120 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 121 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 122 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 123 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Strong investments in infrastructural development to offer opportunities for market growth
TABLE 124 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 125 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 126 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 127 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 128 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 129 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Rising procedural volume to ensure sustained demand for medical gases
TABLE 130 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 131 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 132 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 133 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 134 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 135 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 136 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 139 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 140 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING PUBLIC-PRIVATE PARTNERSHIPS FOR HEALTHCARE DEVELOPMENT TO PROMOTE ADOPTION OF MEDICAL NITROUS OXIDE
9.5.2 LATIN AMERICA: RECESSION IMPACT
TABLE 142 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 143 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 144 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 145 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 146 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 147 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 148 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 154 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL NITROUS OXIDE MARKET
10.3 REVENUE ANALYSIS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL NITROUS OXIDE MARKET, 2018–2022 (USD MILLION)
10.4 MARKET SHARE ANALYSIS
FIGURE 34 MEDICAL NITROUS OXIDE MARKET SHARE ANALYSIS (2022)
TABLE 155 MEDICAL NITROUS OXIDE MARKET: DEGREE OF COMPETITION
10.5 MARKET RANKING ANALYSIS
FIGURE 35 MEDICAL NITROUS OXIDE MARKET RANKING, BY KEY PLAYER, 2022
10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 36 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
10.6.5 COMPANY FOOTPRINT
FIGURE 37 MEDICAL NITROUS OXIDE MARKET: COMPANY FOOTPRINT
TABLE 156 MEDICAL NITROUS OXIDE MARKET: TYPE FOOTPRINT
TABLE 157 MEDICAL NITROUS OXIDE MARKET: APPLICATION FOOTPRINT
TABLE 158 MEDICAL NITROUS OXIDE MARKET: END-USER FOOTPRINT
TABLE 159 MEDICAL NITROUS OXIDE MARKET: REGIONAL FOOTPRINT
10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES
10.7.1 PROGRESSIVE COMPANIES
10.7.2 RESPONSIVE COMPANIES
10.7.3 DYNAMIC COMPANIES
10.7.4 STARTING BLOCKS
FIGURE 38 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
10.7.5 COMPETITIVE BENCHMARKING
10.7.5.1 Detailed list of key startups/SMEs
TABLE 160 MEDICAL NITROUS OXIDE: DETAILED LIST OF KEY STARTUPS/SMES
10.7.5.2 Competitive benchmarking of key startups/SMEs
TABLE 161 MEDICAL NITROUS OXIDE: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPANY EVALUATION AND FINANCIAL METRICS
FIGURE 39 EV/EBITDA OF KEY VENDORS
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL NITROUS OXIDE VENDORS
10.10 COMPETITIVE SCENARIO
10.10.1 DEALS
TABLE 162 MEDICAL NITROUS OXIDE MARKET: DEALS, JANUARY 2020– JANUARY 2024
10.10.2 EXPANSIONS
TABLE 163 MEDICAL NITROUS OXIDE MARKET: EXPANSIONS, JANUARY 2020–JANUARY 2024
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 AIR LIQUIDE
TABLE 164 AIR LIQUIDE: COMPANY OVERVIEW
FIGURE 41 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
11.1.2 LINDE PLC
TABLE 165 LINDE PLC: COMPANY OVERVIEW
FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2022)
11.1.3 SOL SPA
TABLE 166 SOL SPA: COMPANY OVERVIEW
FIGURE 43 SOL SPA: COMPANY SNAPSHOT (2022)
11.1.4 TAIYO NIPPON SANSO CORPORATION
TABLE 167 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW
FIGURE 44 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2023)
11.1.5 NORCO INC.
TABLE 168 NORCO INC.: COMPANY OVERVIEW
11.1.6 SOUTHERN GAS LIMITED
TABLE 169 SOUTHERN GAS LIMITED: COMPANY OVERVIEW
FIGURE 45 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2022)
11.1.7 ELLENBARRIE INDUSTRIAL GASES
TABLE 170 ELLENBARRIE INDUSTRIAL GASES: COMPANY OVERVIEW
FIGURE 46 ELLENBARRIE INDUSTRIAL GASES: COMPANY SNAPSHOT (2020)
11.1.8 CALOX INC.
TABLE 171 CALOX INC.: COMPANY OVERVIEW
11.1.9 STEELMAN GASES PVT. LTD.
TABLE 172 STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW
11.1.10 NEXAIR
TABLE 173 NEXAIR: COMPANY OVERVIEW
11.1.11 OXYGEN & ARGON WORKS LTD.
TABLE 174 OXYGEN & ARGON WORKS LTD.: COMPANY OVERVIEW
11.1.12 GULFCRYO
TABLE 175 GULFCRYO: COMPANY OVERVIEW
11.1.13 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
TABLE 176 CHENGDU TAIYO INDUSTRIAL GASES CO. LTD.: COMPANY OVERVIEW
11.1.14 JIANGSU HUAZHONG GAS CO., LTD.
TABLE 177 JIANGSU HAUZHONG GAS CO., LTD.: COMPANY OVERVIEW
11.1.15 CARBIDE AND CHEMICALS
TABLE 178 CARBIDE AND CHEMICALS: COMPANY OVERVIEW
11.1.16 AMERICAN WELDING & GAS
TABLE 179 AMERICAN WELDING & GAS: COMPANY OVERVIEW
11.1.17 ASIA INDUSTRIAL GASES PTE. LTD.
TABLE 180 ASIA INDUSTRIAL GASES PTE. LTD.: COMPANY OVERVIEW
11.1.18 MIDDLESEX GASES & TECHNOLOGY INC.
TABLE 181 MIDDLESEX GASES & TECHNOLOGIES INC.: COMPANY OVERVIEW
11.1.19 AMERITANX CYLINDERS
TABLE 182 AMERITANX CYLINDERS: COMPANY OVERVIEW
11.1.20 CRYOCARB
TABLE 183 CRYOCARB: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 HOLSTON GASES
11.2.2 AOPL
11.2.3 BUTLER GAS PRODUCTS COMPANY
11.2.4 GRUPPO SIAD
11.2.5 ANDY OXY CO., INC.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
